SMARCA5 and acute myeloid leukemia: In this context, SMARCA5 regulates the access to DNA and is upregulated in acute myeloid leukemia [41], while TRIM71 is a post-transcriptional repressor involved in the cell cycle maintaining embryonic stem cell growth and in the processing of the presentation of class I MHC-mediated antigen [42].